sNN0029
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for sNN0029, covering 2011-12-06 to 2016-01-27. Get the full timeline:
Most recent: Clinical Trial Update: An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis [Phase 1, Phase 2]